Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Renal osteodystrophy]

T Shoji1, F Marumo

  • 1Yokosuka Kyosai Hospital Kidney Center.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|April 1, 1993
PubMed
Summary
This summary is machine-generated.

Long-term hemodialysis patients showed reduced subperiosteal bone resorption after active vitamin D administration. New vitamin D analogues may better manage secondary hyperparathyroidism without causing hypercalcemia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hyponatremia with consciousness disturbance caused by omeprazole administration. A case report and literature review.

Digestive diseases and sciences·1996
Same author

Shared amino acid motifs in T-cell receptor beta junctional regions of bronchoalveolar T cells in patients with pulmonary sarcoidosis.

American journal of respiratory and critical care medicine·1996
Same author

Chloride transport across kidney epithelia through CLC chloride channels.

Nihon Jinzo Gakkai shi·1996
Same author

Specific binding sites for proadrenomedullin N-terminal 20 peptide (PAMP) in the rat.

Endocrinology·1996
Same author

Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.

American journal of kidney diseases : the official journal of the National Kidney Foundation·1996
Same author

Mild hypoxia induces hypertrophy of cultured neonatal rat cardiomyocytes: a possible endogenous endothelin-1-mediated mechanism.

Journal of molecular and cellular cardiology·1996
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Area of Science:

  • Nephrology
  • Endocrinology
  • Radiology

Background:

  • Long-term hemodialysis can lead to significant bone abnormalities.
  • Subperiosteal bone resorption is a key indicator of renal osteodystrophy.
  • Vitamin D therapy has evolved to manage complications in dialysis patients.

Purpose of the Study:

  • To compare bone X-ray findings, specifically subperiosteal bone resorption, in hemodialysis patients before and after a decade of active vitamin D administration.
  • To evaluate the efficacy and limitations of active vitamin D in managing secondary hyperparathyroidism and associated bone disease.
  • To explore novel vitamin D analogues for improved therapeutic outcomes.

Main Methods:

  • Retrospective analysis of bone X-ray findings in hemodialysis patients from 1978 and 1991.

Related Experiment Videos

  • Comparison of the incidence of subperiosteal bone resorption between the two time points.
  • Review of vitamin D administration protocols and patient outcomes.

    • Main Results:

    • A significant decrease in the frequency of subperiosteal bone resorption was observed in 1991 compared to 1978.
    • Active vitamin D administration, implemented for ten years by 1991, correlated with reduced bone resorption.
    • While effective, standard active vitamin D therapy showed limitations, including occasional treatment failure and hypercalcemia in advanced secondary hyperparathyroidism.

    Conclusions:

    • Active vitamin D therapy has demonstrably improved bone health in long-term hemodialysis patients by reducing subperiosteal bone resorption.
    • Emerging vitamin D analogues, such as 22-oxacalcitriol, show promise in suppressing parathyroid hormone (PTH) secretion without inducing hypercalcemia, offering a potentially superior treatment for secondary hyperparathyroidism.